MAKO Surgical Corp.  

(Public, NASDAQ:MAKO)   Watch this stock  
Find more results for MAKO
- Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -1.21
Shares 51.51M
Beta     -
Inst. own 75%

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -93.38% -31.69%
Operating margin -93.35% -34.58%
EBITD margin - -27.18%
Return on average assets -60.65% -22.09%
Return on average equity -78.53% -26.98%
Employees 436 -
CDP Score - -


2555 Davie Rd
DAVIE, FL 33317-7424
United States - Map
+1-954-9272044 (Phone)
+1-954-9270446 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


MAKO Surgical Corp. (MAKO) is a medical device company, which markets its advanced robotic arm solution, joint specific applications for the knee and hip and orthopedic implants for orthopedic procedures. The Company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific, osteoarthritic disease. MAKOplasty is performed using the Company's RIO Robotic Arm Interactive Orthopedic system (RIO). The RIO is a technology platform that utilizes tactile guided robotic arm technology and patient specific planning and visualization to offer reproducible precision to surgeons. In October 2013, MAKO Surgical Corp. completed the acquisition of Pipeline Biomedical Holdings, Inc.'s business, which is engaged in the design, development, manufacture and commercialization of orthopedic devices and related instruments for use with both robotic devices and manual medical procedures.